Finesse launches new core modules for off-line data processing in fourth generation TruBio DV software

Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life science process applications, has announced the official launch of two new core modules for off-line data processing in its fourth generation TruBio DV software.  These modules are targeted at enabling bioprocessing specialists to manage data from third party equipment and process analyzers, and obtain automated electronic records of their batch.  Since its first launch in 2007, TruBio DV continues to be powered by a DeltaV Controller from Emerson Process Management, and is fully compatible with DeltaV versions 9.3 through 11.3.  

"TruBio DV software was originally developed to provide automation hardware independence and to utilize best in class components for upstream process management.  TruBio DV 2.0 was optimized to enable easy scale-up and scale-down between R&D, process development, and cGMP manufacturing.  TruBio DV 3.0 introduced OPC-based communication with third party analyzers such as the Nova BioProfile400 and FLEX back in 2008, and demonstrated automated feeding strategies and intelligent management of redundant process sensors for pH measurement," stated Basil Zimmo, VP of Software at Finesse.  

RemoteView OPC allows seamless digital communication with third party process equipment and off-line process analyzers, so that TruBio DV can overlay on existing bioreactors to extend their useful life.  BatchReport is an integrated electronic batch report generator that leverages all process data consolidated into the TruBio/DeltaV historian.  

"To illustrate the power of TruBio DV 4.0 we look at existing examples: TruBio can overlay and direct over one hundred controllers from diverse manufacturers including Sartorius, Applikon, New Brunswick and DasGip, with customized cell-viability-based feed strategies using off-line measurements from a Nova FLEX, and simultaneously produce an electronic record comparing several bioreactors running in parallel for efficient design of experiment," summarized Mr. Zimmo.